Floatz logo

DHA

Obesity, Abdominal

Technological Centre of Nutrition and Health, SpainSmall moleculePhase 2Dormant
B
57/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
42/ 100
Competitive Position
95/ 100

Competitive context

7 Active assets in the Obesity, Abdominal cohort.

Asset / SponsorPhaseRating
Metformin
RenJi Hospital
Phase 4BBB
UMBELLATINE
China National Center for Cardiovascular Diseases
Phase 4BB
Letrozole
RenJi Hospital
Phase 4BB
17-beta-estradiol
University of Colorado, Denver
Phase 4BB
VITAMIN D
Alborz Medical University
Phase 2B

View all 17 →

Same molecule, other indications

DHA is also rated in:

metabolic dysfunction-associated steatohepatitisDormant
BB
Indicative ·
64 / 100
View asset →
metabolic dysfunction-associated steatotic liver diseaseDormant
BB
Indicative ·
64 / 100
View asset →
panniculitisDormant
B
Indicative ·
57 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →